Hang Ruan

4PUBLICATIONS
6CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radio frequency engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 05, 2026
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

|Apr 23, 2026
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells.

|Jan 11, 2024
Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.

Shenghui Weng, Xinyi Yang, Nannan Yu

|Dec 03, 2022
Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.

Shenghui Weng, Hang Ruan

Pageof 1

Frequent Collaborators

1 joint publications

Shenghui Weng

1 joint publications

Peng-Cheng Wang

1 joint publications

Udhaya Kumar S

1 joint publications

Leng Han